Filing metadata

Accession number
0001127602-24-016107
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
May 21, 2024
Reporting period
May 20, 2024
Description
Insider transaction

Explore SEC Filings Hub